Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)

The American Journal of Cardiology

Volumn 75, Issue 7, 1995, Pages 455-459

  Crouse III, John Robert ^a,b   Byington, Robert Patrick ^a,b   Bond, M Gene ^a,b   Espefand, Mark Andrew ^a,b   Craven, Timothy Edward ^a,b   Sprinkle, Janine Worthy ^a,b   McGovern, Mark Edward ^a,b   Furberg, Curt Daniel ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUNICA MEDIA;

ARTERIOSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL; DOUBLE-BLIND METHOD; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; PRAVASTATIN;

EID: 0028910703     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80580-3     Document Type: Article

References (27)

1. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case control study
2. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging
3. Detection and monitoring of asymptomatic atherosclerosis in clinical trials
4. Individual variation in susceptibility to extracranial carotid atherosclerosis
5. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland
6. Pravastatin, Lipids, and Atherosclerosis in the Carotid arteries: design features of a clinical trial with atherosclerosis outcome
7. Lipoprotein-cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study
8. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
9. Pravastatin, lipids, and major coronary events
10. Random-effects models for longitudinal data
11. Unbalanced repeated measures models with structured covariance matrices
12. Unbalanced repeated measures models with structured covariance matrices
13. Arterial enlargement in the ARIC cohort. In vivo quantification of arterial enlargement
14. Evaluation of methods for quantifying lumen stenosis and atherosclerosis
15. Beneficial effects of colestipol-niacin therapy on the common carotid artery
16. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis
17. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study
18. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
19. KAPS: the effect of pravastatin on atherosclerotic progression in carotid and femoral arteries
20. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
21. Compensation of the arterial lumen for wall thickening: the Atherosclerosis Risk in Communities (ARIC) study
22. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography
23. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease
24. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study
25. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I)